HIE (hypoxic-ischemic encephalopathy) is a birth injury that children obtain due to lack of oxygen and blood flow at, or near, the time of birth. The condition causes brain injuries, and often results ...

Neonatal hypoxic–ischemic encephalopathy is an important cause of death as well as long-term disability in survivors. Erythropoietin has been hypothesized to have neuroprotective effects in infants ...

Amsterdam, February 22, 2010 – IOS Press announces publication of a special issue of NeuroRehabilitation: An International Journal (NRE) devoted specifically to hypoxic-ischemic brain injury (HI-BI), ...

Many infants with mild neonatal encephalopathy face long-term disabilities, highlighting the need for evidence-based treatments such as therapeutic cooling Mild neonatal encephalopathy is determined ...

High seizure burden and abnormal aEEG patterns, not seizures alone, are linked to poor outcomes in newborns with hypoxic-ischemic encephalopathy A high seizure burden, as well as a persistent abnormal ...

Study shows that perinatal arterial ischemic stroke often coexists with hypoxic-ischemic encephalopathy in infants receiving therapeutic hypothermia This article clearly shows that there are children ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A Virginia-based biotech company has announced dosing of ...

<0> Research and MarketsLaura Wood, Senior Manager.U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716Sector: </0> () has announced the addition of the report to their offering. Global Markets ...

The Food and Drug Administration (FDA) has granted Orphan Drug designation to PIC1-dPEG24 (ReAlta Life Sciences) for the treatment of hypoxic-ischemic encephalopathy (HIE) in neonates. The Food and ...